Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route

Abstract : Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter physiologically active in the central nervous system (CNS), being synthesised and delivered by GABAergic neurons. It is, however, pharmacologically devoid of CNS activity when presented externally to brain because of limited blood-brain barrier diffusion and intensive breakdown by astrocyte GABA transaminase. We show herein that extracerebral administration may be, however, pharmacologically effective in controlling experimental convulsive attacks when GABA is submitted to sublimation under vacuum just before use. Though initially enigmatic because nuclear magnetic resonance (NMR) and infrared (IR) analyses identified the sublimation-derived compound to be the reference zwitterionic GABA, this observation was understood by showing that the reference and sublimated GABAs were monoclinic and tetragonal phases of GABA solid, respectively.
Type de document :
Article dans une revue
Medicinal Chemistry Research, Springer Verlag, 2009, 18 (4), p. 255-267
Liste complète des métadonnées

https://hal-univ-artois.archives-ouvertes.fr/hal-00545967
Contributeur : Wilfried Déplanques <>
Soumis le : lundi 13 décembre 2010 - 13:48:26
Dernière modification le : mardi 5 décembre 2017 - 13:10:03

Identifiants

  • HAL Id : hal-00545967, version 1

Collections

Citation

Joseph Vamecq, Yves Feutelais, Pierre Maurois, Mehrez Sghaier, Emma Dichi, et al.. Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route. Medicinal Chemistry Research, Springer Verlag, 2009, 18 (4), p. 255-267. 〈hal-00545967〉

Partager

Métriques

Consultations de la notice

95